Episode 55: NEN Treatment Sequencing & Strategy
In this episode, medical oncologist Dr. Chandrikha Chandrasekharan from MD Anderson Cancer Center breaks down how treatment decisions are made and sequenced for patients with neuroendocrine neoplasms ...
26 Sep 58min
Episode 54: "Focus on Cabozantinib" with Dr. Vijayvergia
Since its FDA approval on March 26, 2025, cabozantinib has emerged as the newest treatment option for neuroendocrine tumors (NET) patients—adding another valuable tool to the treatment toolbox. It’s b...
13 Aug 50min
Episode 53: Spotlight on Surgical Oncology
In this episode, surgical oncologist Dr. Seth Concors of Emory’s Winship Cancer Institute discusses the role of the surgical oncologist within the multidisciplinary care team for neuroendocrine cancer...
12 Apr 1h
Episode 52: "Spotlight on Genetic Counselors" with Samantha Greenberg, PhD, MS, MPH, CGC
ABOUT THIS EPISODE Who is a genetic counselor, and who should see one? How do they fit into the neuroendocrine cancer care team? In this episode, Samantha Greenberg, PhD, MS, MPH, CGC, Director of the...
3 Feb 1h 3min
Episode 51: "Highlights of the 2025 NANETS Symposium" with Dr. Will Pegna
ABOUT THIS EPISODE In this special annual episode, OHSU medical oncologist Dr. Guillaume (“Will”) Pegna joins us once again to break down the highlights from the 2025 North American Neuroendocrine Tum...
21 Dec 20251h 11min
"Spotlight on Pharmacists" with Amanda Cass, PharmD, BCPS, BCOP
ABOUT THIS EPISODE Who is a pharmacist, and how are they involved in the care of neuroendocrine cancer patients? In this episode, Dr. Amanda Cass, a clinical pharmacist in the Thoracic Oncology Clini...
28 Nov 202554min
"Understanding Carcinoid Syndrome & GLP-1 Drugs in Neuroendocrine Tumors" with Dr. Joseph Dillon
ABOUT THIS EPISODE Carcinoid syndrome can be confusing and often difficult to diagnose. In this episode, Dr. Joseph Dillon, Endocrinologist and Director of the University of Iowa Neuroendocrine Multi...
22 Nov 20251h 9min
"NEN Treatments: Focus On DLL3" with Dr. Rohit Thummalapalli
ABOUT THIS EPISODE DLL3 is emerging as a promising new target for neuroendocrine cancers. In this episode, Dr. Rohit Thummalapalli, medical oncologist at Memorial Sloan Kettering Cancer Center, explai...
6 Okt 202555min
